Assessments conducted in 2013 on the management of TB drugs in Ukraine highlighted specific pharmaceutical management challenges, particularly in terms of data collection, capacity constraints, data quality, and frequency of reporting. Of note, cases of TB within the penitentiary system―roughly 15% of all TB cases in Ukraine―were poorly tracked; even when available, data from the penitentiary system were not integrated with the information system at the Ministry of Health (MOH), which skewed TB surveillance data. Furthermore, ongoing political unrest and personnel changes at the MOH continue to hinder efforts to address these challenges.
